{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T04:18:42Z","timestamp":1785557922742,"version":"3.56.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,12,30]],"date-time":"2023-12-30T00:00:00Z","timestamp":1703894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,30]],"date-time":"2023-12-30T00:00:00Z","timestamp":1703894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s11102-023-01376-7","type":"journal-article","created":{"date-parts":[[2023,12,30]],"date-time":"2023-12-30T07:02:02Z","timestamp":1703919722000},"page":"169-177","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Acromegaly increases depressive symptoms and reduces quality of life of cohabitants"],"prefix":"10.1007","volume":"27","author":[{"given":"Serhat","family":"Uysal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cem","family":"Sulu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zehra","family":"Kara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilker","family":"Ihtiyaroglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irem","family":"Ozkal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serdar","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabriye Sibel","family":"Taze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Murat","family":"Kirpinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senol","family":"Turan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinar","family":"Kadioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,30]]},"reference":[{"key":"1376_CR1","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1056\/NEJMra1810772","volume":"382","author":"S Melmed","year":"2020","unstructured":"Melmed S (2020) Pituitary-Tumor Endocrinopathies. N Engl J Med 382:937\u2013950. https:\/\/doi.org\/10.1056\/NEJMra1810772","journal-title":"N Engl J Med"},{"key":"1376_CR2","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1530\/EJE-18-0925","volume":"180","author":"J Sibeoni","year":"2019","unstructured":"Sibeoni J, Manolios E, Verneuil L et al (2019) Patients\u2019 perspectives on acromegaly diagnostic delay: a qualitative study. Eur J Endocrinol 180:339\u2013352. https:\/\/doi.org\/10.1530\/EJE-18-0925","journal-title":"Eur J Endocrinol"},{"key":"1376_CR3","doi-asserted-by":"publisher","first-page":"3648","DOI":"10.1210\/jc.2009-2570","volume":"95","author":"C Berg","year":"2010","unstructured":"Berg C, Petersenn S, Lahner H et al (2010) Cardiovascular Risk factors in patients with uncontrolled and long-term acromegaly: comparison with Matched Data from the General Population and the Effect of Disease Control. J Clin Endocrinol Metab 95:3648\u20133656. https:\/\/doi.org\/10.1210\/jc.2009-2570","journal-title":"J Clin Endocrinol Metab"},{"key":"1376_CR4","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1530\/EJE-10-1050","volume":"164","author":"S Fieffe","year":"2011","unstructured":"Fieffe S, Morange I, Petrossians P et al (2011) Diabetes in acromegaly, prevalence, risk factors, and evolution: data from the French Acromegaly Registry. Eur J Endocrinol 164:877\u2013884. https:\/\/doi.org\/10.1530\/EJE-10-1050","journal-title":"Eur J Endocrinol"},{"key":"1376_CR5","first-page":"527","volume":"79","author":"B Trotman-Dickenson","year":"1991","unstructured":"Trotman-Dickenson B, Weetman AP, Hughes JM (1991) Upper airflow obstruction and pulmonary function in acromegaly: relationship to Disease activity. Q J Med 79:527\u2013538","journal-title":"Q J Med"},{"key":"1376_CR6","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1530\/EJE-08-0845","volume":"160","author":"MJE Wassenaar","year":"2009","unstructured":"Wassenaar MJE, Biermasz NR, van Duinen N et al (2009) High prevalence of arthropathy, according to the definitions of radiological and clinical osteoarthritis, in patients with long-term cure of acromegaly: a case\u2013control study. Eur J Endocrinol 160:357\u2013365. https:\/\/doi.org\/10.1530\/EJE-08-0845","journal-title":"Eur J Endocrinol"},{"key":"1376_CR7","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/s41574-018-0058-5","volume":"14","author":"S Melmed","year":"2018","unstructured":"Melmed S, Bronstein MD, Chanson P et al (2018) A Consensus Statement on acromegaly therapeutic outcomes. Nat Rev Endocrinol 14:552\u2013561. https:\/\/doi.org\/10.1038\/s41574-018-0058-5","journal-title":"Nat Rev Endocrinol"},{"key":"1376_CR8","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1007\/s11102-011-0310-7","volume":"14","author":"A Ben-Shlomo","year":"2011","unstructured":"Ben-Shlomo A, Sheppard MC, Stephens JM et al (2011) Clinical, quality of life, and economic value of acromegaly Disease control. Pituitary 14:284\u2013294. https:\/\/doi.org\/10.1007\/s11102-011-0310-7","journal-title":"Pituitary"},{"key":"1376_CR9","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.2147\/PPA.S102302","volume":"10","author":"EA Christofides","year":"2016","unstructured":"Christofides EA (2016) Clinical importance of achieving biochemical control with medical therapy in adult patients with acromegaly. Patient Prefer Adherence Volume 10:1217\u20131225. https:\/\/doi.org\/10.2147\/PPA.S102302","journal-title":"Patient Prefer Adherence Volume"},{"key":"1376_CR10","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1007\/s11102-015-0636-7","volume":"18","author":"CD Andela","year":"2015","unstructured":"Andela CD, Scharloo M, Pereira AM et al (2015) Quality of life (QoL) impairments in patients with a pituitary adenoma: a systematic review of QoL studies. Pituitary 18:752\u2013776. https:\/\/doi.org\/10.1007\/s11102-015-0636-7","journal-title":"Pituitary"},{"key":"1376_CR11","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s11102-022-01224-0","volume":"25","author":"A Kimball","year":"2022","unstructured":"Kimball A, Dichtel LE, Yuen KCJ et al (2022) Quality of life after long-term biochemical control of acromegaly. Pituitary 25:531\u2013539. https:\/\/doi.org\/10.1007\/s11102-022-01224-0","journal-title":"Pituitary"},{"key":"1376_CR12","doi-asserted-by":"publisher","first-page":"K19","DOI":"10.1530\/EJE-21-0537","volume":"185","author":"R Fourneaux","year":"2021","unstructured":"Fourneaux R, Vermalle M, Albarel F et al (2021) Acromegaly in remission: a view from the partner. Eur J Endocrinol 185:K19\u2013K23. https:\/\/doi.org\/10.1530\/EJE-21-0537","journal-title":"Eur J Endocrinol"},{"key":"1376_CR13","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1172\/JCI39375","volume":"119","author":"S Melmed","year":"2009","unstructured":"Melmed S (2009) Acromegaly pathogenesis and treatment. J Clin Invest 119:3189\u20133202. https:\/\/doi.org\/10.1172\/JCI39375","journal-title":"J Clin Invest"},{"key":"1376_CR14","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.1210\/jc.2014-2700","volume":"99","author":"L Katznelson","year":"2014","unstructured":"Katznelson L, Laws ER, Melmed S et al (2014) Acromegaly: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 99:3933\u20133951. https:\/\/doi.org\/10.1210\/jc.2014-2700","journal-title":"J Clin Endocrinol Metab"},{"key":"1376_CR15","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1530\/eje.1.02214","volume":"155","author":"SM Webb","year":"2006","unstructured":"Webb SM, Badia X, Surinach NL (2006) Validity and clinical applicability of the acromegaly quality of life questionnaire, AcroQoL: a 6-month prospective study. Eur J Endocrinol 155:269\u2013277. https:\/\/doi.org\/10.1530\/eje.1.02214","journal-title":"Eur J Endocrinol"},{"key":"1376_CR16","first-page":"OC20","volume":"11","author":"SM Webb","year":"2006","unstructured":"Webb SM, Colao A, Caron P et al (2006) A European prospective real-life observational study of quality of life in patients with acromegaly. Endocr Abstr 11:OC20","journal-title":"Endocr Abstr"},{"key":"1376_CR17","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1097\/00005650-199303000-00006","volume":"31","author":"CA McHorney","year":"1993","unstructured":"McHorney CA, Ware J Jr, Raczek AE (1993) The MOS 36-Item short-Form Health Survey (SF-36). Med Care 31:247\u2013263. https:\/\/doi.org\/10.1097\/00005650-199303000-00006","journal-title":"Med Care"},{"key":"1376_CR18","first-page":"102","volume":"12","author":"H Ko\u00e7yi\u011fit","year":"1999","unstructured":"Ko\u00e7yi\u011fit H, Aydemir \u00d6, \u00d6lmez N, Memi\u015f A (1999) K\u0131sa form-36 (KF36)\u2019n\u0131n T\u00fcrk\u00e7e versiyonunun g\u00fcvenirlili\u011fi ve ge\u00e7erlili\u011fi. \u0130la\u00e7 ve Tedavi Derg 12:102\u2013106","journal-title":"\u0130la\u00e7 ve Tedavi Derg"},{"key":"1376_CR19","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1037\/0022-006X.56.6.893","volume":"56","author":"AT Beck","year":"1988","unstructured":"Beck AT, Epstein N, Brown G, Steer RA (1988) An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 56:893\u2013897. https:\/\/doi.org\/10.1037\/0022-006X.56.6.893","journal-title":"J Consult Clin Psychol"},{"key":"1376_CR20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1080\/07317115.2011.524600","volume":"34","author":"BP Yochim","year":"2010","unstructured":"Yochim BP, Mueller AE, June A, Segal DL (2010) Psychometric properties of the geriatric anxiety scale: comparison to the Beck anxiety inventory and geriatric anxiety inventory. Clin Gerontol 34:21\u201333. https:\/\/doi.org\/10.1080\/07317115.2011.524600","journal-title":"Clin Gerontol"},{"key":"1376_CR21","first-page":"163","volume":"12","author":"M Ulusoy","year":"1998","unstructured":"Ulusoy M, \u015eahin N, Erkmen H (1998) Turkish version of the Beck anxiety inventory: Psychometric Properties. J Cogn Psychother 12:163\u2013171","journal-title":"J Cogn Psychother"},{"key":"1376_CR22","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","volume":"4","author":"A Beck","year":"1961","unstructured":"Beck A, Ward C, Mendelson M et al (1961) An inventory for Measuring Depression. Arch Gen Psychiatry 4:561\u2013571. https:\/\/doi.org\/10.1001\/archpsyc.1961.01710120031004","journal-title":"Arch Gen Psychiatry"},{"key":"1376_CR23","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/BF01186280","volume":"11","author":"PC Kendall","year":"1987","unstructured":"Kendall PC, Hollon SD, Beck AT et al (1987) Issues and recommendations regarding use of the Beck Depression Inventory. Cognit Ther Res 11:289\u2013299. https:\/\/doi.org\/10.1007\/BF01186280","journal-title":"Cognit Ther Res"},{"key":"1376_CR24","first-page":"3","volume":"7","author":"N Hisli","year":"1989","unstructured":"Hisli N (1989) Beck Depresyon Envanterinin \u00fcniversite \u00f6\u011frencileri i\u00e7in ge\u00e7erli\u011fi, g\u00fcvenirli\u011fi. Psikol Derg 7:3\u201313","journal-title":"Psikol Derg"},{"key":"1376_CR25","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1093\/geront\/20.6.649","volume":"20","author":"SH Zarit","year":"1980","unstructured":"Zarit SH, Reever KE, Bach-Peterson J (1980) Relatives of the impaired Elderly: correlates of feelings of Burden. Gerontologist 20:649\u2013655. https:\/\/doi.org\/10.1093\/geront\/20.6.649","journal-title":"Gerontologist"},{"key":"1376_CR26","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1093\/geront\/41.5.652","volume":"41","author":"M B\u00e9dard","year":"2001","unstructured":"B\u00e9dard M, Molloy DW, Squire L et al (2001) The Zarit Burden interview: a new short version and screening version. Gerontologist 41:652\u2013657. https:\/\/doi.org\/10.1093\/geront\/41.5.652","journal-title":"Gerontologist"},{"key":"1376_CR27","first-page":"85","volume":"11","author":"F \u0130nci","year":"2008","unstructured":"\u0130nci F, Erdem M (2008) Bak\u0131m Verme Y\u00fck\u00fc \u00d6l\u00e7e\u011fi\u2019nin T\u00fcrk\u00e7e\u2019ye Uyarlanmas\u0131 Ge\u00e7erlilik Ve G\u00fcvenilirli\u011fi. Atat\u00fcrk \u00dcniversitesi Hem\u015firelik Y\u00fcksekokulu Derg 11:85\u201395","journal-title":"Atat\u00fcrk \u00dcniversitesi Hem\u015firelik Y\u00fcksekokulu Derg"},{"key":"1376_CR28","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1037\/0022-3514.51.6.1173","volume":"51","author":"RM Baron","year":"1986","unstructured":"Baron RM, Kenny DA (1986) The moderator\u2013mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol 51:1173\u20131182. https:\/\/doi.org\/10.1037\/0022-3514.51.6.1173","journal-title":"J Pers Soc Psychol"},{"key":"1376_CR29","doi-asserted-by":"publisher","first-page":"290","DOI":"10.2307\/270723","volume":"13","author":"ME Sobel","year":"1982","unstructured":"Sobel ME (1982) Asymptotic confidence intervals for Indirect effects in Structural equation models. Sociol Methodol 13:290. https:\/\/doi.org\/10.2307\/270723","journal-title":"Sociol Methodol"},{"key":"1376_CR30","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1080\/03637750903310360","volume":"76","author":"AF Hayes","year":"2009","unstructured":"Hayes AF (2009) Beyond Baron and Kenny: Statistical Mediation Analysis in the New Millennium. Commun Monogr 76:408\u2013420. https:\/\/doi.org\/10.1080\/03637750903310360","journal-title":"Commun Monogr"},{"key":"1376_CR31","doi-asserted-by":"publisher","first-page":"717","DOI":"10.3758\/BF03206553","volume":"36","author":"KJ Preacher","year":"2004","unstructured":"Preacher KJ, Hayes AF (2004) SPSS and SAS procedures for estimating indirect effects in simple mediation models. Behav Res Methods Instruments Comput 36:717\u2013731. https:\/\/doi.org\/10.3758\/BF03206553","journal-title":"Behav Res Methods Instruments Comput"},{"key":"1376_CR32","doi-asserted-by":"publisher","first-page":"879","DOI":"10.3758\/BRM.40.3.879","volume":"40","author":"KJ Preacher","year":"2008","unstructured":"Preacher KJ, Hayes AF (2008) Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behav Res Methods 40:879\u2013891. https:\/\/doi.org\/10.3758\/BRM.40.3.879","journal-title":"Behav Res Methods"},{"key":"1376_CR33","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.1210\/jc.2004-1565","volume":"90","author":"SV Rowles","year":"2005","unstructured":"Rowles SV, Prieto L, Badia X et al (2005) Quality of life (QOL) in patients with acromegaly is severely impaired: Use of a Novel measure of QOL: Acromegaly Quality of Life Questionnaire. J Clin Endocrinol Metab 90:3337\u20133341. https:\/\/doi.org\/10.1210\/jc.2004-1565","journal-title":"J Clin Endocrinol Metab"},{"key":"1376_CR34","doi-asserted-by":"publisher","unstructured":"Ballesteros-Herrera D, Brise\u00f1o\u2010Hern\u00e1ndez P, P\u00e9rez\u2010Esparza R, Portocarrero\u2010Ortiz LA (2021) Differences in quality of life between genders in acromegaly. Endocrinol Diabetes Metab 4. https:\/\/doi.org\/10.1002\/edm2.229","DOI":"10.1002\/edm2.229"},{"key":"1376_CR35","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1177\/1359105317695427","volume":"24","author":"CD Andela","year":"2019","unstructured":"Andela CD, Tiemensma J, Kaptein AA et al (2019) The partner\u2019s perspective of the impact of pituitary Disease: looking beyond the patient. J Health Psychol 24:1687\u20131697. https:\/\/doi.org\/10.1177\/1359105317695427","journal-title":"J Health Psychol"},{"key":"1376_CR36","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.1752-9824.2009.01014.x","volume":"1","author":"T Dunning","year":"2009","unstructured":"Dunning T, Alford F (2009) Pituitary Disease - perspectives of patients and partners. J Nurs Healthc Chronic Illn 1:139\u2013146. https:\/\/doi.org\/10.1111\/j.1752-9824.2009.01014.x","journal-title":"J Nurs Healthc Chronic Illn"},{"key":"1376_CR37","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1016\/j.jfma.2019.05.007","volume":"118","author":"F-Y Tseng","year":"2019","unstructured":"Tseng F-Y, Chen S-T, Chen J-F et al (2019) Correlations of clinical parameters with quality of life in patients with acromegaly: Taiwan Acromegaly Registry. J Formos Med Assoc 118:1488\u20131493. https:\/\/doi.org\/10.1016\/j.jfma.2019.05.007","journal-title":"J Formos Med Assoc"},{"key":"1376_CR38","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1530\/EJE-11-0853","volume":"166","author":"MR Postma","year":"2012","unstructured":"Postma MR, Netea-Maier RT, van den Berg G et al (2012) Quality of life is impaired in association with the need for prolonged postoperative therapy by somatostatin analogs in patients with acromegaly. Eur J Endocrinol 166:585\u2013592. https:\/\/doi.org\/10.1530\/EJE-11-0853","journal-title":"Eur J Endocrinol"},{"key":"1376_CR39","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1007\/s11102-015-0665-2","volume":"18","author":"K Yoshida","year":"2015","unstructured":"Yoshida K, Fukuoka H, Matsumoto R et al (2015) The quality of life in acromegalic patients with biochemical remission by Surgery alone is superior to that in those with pharmaceutical therapy without radiotherapy. Using the Newly Developed Japanese Version of the AcroQoL Pituitary 18:876\u2013883. https:\/\/doi.org\/10.1007\/s11102-015-0665-2","journal-title":"Using the Newly Developed Japanese Version of the AcroQoL Pituitary"},{"key":"1376_CR40","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s11102-013-0544-7","volume":"17","author":"H Kepicoglu","year":"2014","unstructured":"Kepicoglu H, Hatipoglu E, Bulut I et al (2014) Impact of treatment satisfaction on quality of life of patients with acromegaly. Pituitary 17:557\u2013563. https:\/\/doi.org\/10.1007\/s11102-013-0544-7","journal-title":"Pituitary"},{"key":"1376_CR41","doi-asserted-by":"publisher","first-page":"5369","DOI":"10.1210\/jc.2004-0669","volume":"89","author":"NR Biermasz","year":"2004","unstructured":"Biermasz NR, van Thiel SW, Pereira AM et al (2004) Decreased quality of life in patients with Acromegaly despite Long-Term cure of growth hormone excess. J Clin Endocrinol Metab 89:5369\u20135376. https:\/\/doi.org\/10.1210\/jc.2004-0669","journal-title":"J Clin Endocrinol Metab"},{"key":"1376_CR42","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1111\/cen.13331","volume":"86","author":"N Kyriakakis","year":"2017","unstructured":"Kyriakakis N, Lynch J, Gilbey SG et al (2017) Impaired quality of life in patients with treated acromegaly despite long-term biochemically stable Disease: results from a 5-years prospective study. Clin Endocrinol (Oxf) 86:806\u2013815. https:\/\/doi.org\/10.1111\/cen.13331","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-023-01376-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-023-01376-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-023-01376-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T08:32:31Z","timestamp":1712910751000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-023-01376-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,30]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["1376"],"URL":"https:\/\/doi.org\/10.1007\/s11102-023-01376-7","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,30]]},"assertion":[{"value":"17 December 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure statement"}},{"value":"Informed consent was obtained from all patients and cohabitants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"This study was approved by the ethics committee of Cerrahpasa Faculty of Medicine (Decision No: 83045809-604.01.01-589465 dated 10 January 2023). All procedures performed aligned with the Declaration of Helsinki.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}